What is Spineart?
Founded in 2005 and headquartered in Switzerland, Spineart is a privately held medical device company dedicated to simplifying surgical procedures. The company designs, develops, and promotes safe and efficient solutions tailored for spine surgeons, operating room teams, and patients. Spineart's focus on innovation in spinal surgery positions it as a key player in the medical technology sector, aiming to improve patient outcomes and surgical efficiency through its specialized product offerings.
How much funding has Spineart raised?
Spineart has raised a total of $55.5M across 2 funding rounds:
Private Equity
$33.5M
Other Financing Round
$22M
Private Equity (2016): $33.5M with participation from GIMV
Other Financing Round (2024): $22M, investors not publicly disclosed
Key Investors in Spineart
GIMV
Gimv is a European investment company specializing in mid-market businesses across sectors like Healthcare and Life Sciences, focusing on sustainable growth and value creation through long-term partnerships.
What's next for Spineart?
The recent major strategic investment of $22M signals a pivotal moment for Spineart, likely enabling accelerated product development, market expansion, and enhanced research initiatives. This capital infusion, following substantial prior backing, suggests the company is poised for significant scaling and further innovation in the spine surgery device market. The strategic nature of this financing may also indicate partnerships or collaborations aimed at strengthening its market position and technological capabilities.
See full Spineart company page
